Results 21 to 30 of about 15,421,997 (282)

Non-medical Use of Prescription Stimulants Among College Students: Non-oral Routes of Administration, Risk Factors, Motivations, and Pathways

Frontiers in Psychiatry, 2021
Introduction: Non-medical use (NMU) of prescription stimulant medications is a continuing public health concern. Stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) are widely available on college campuses, and, as a ...
Stephen F. Butler, Stephen V. Faraone, Anthony L. Rostain, Jeffrey H. Newcorn, Kevin M. Antshel, Rebekkah S. Robbins, Jody L. Green   +6 more
doaj   +1 more source

Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands [PDF]

, 2009
This study aimed at investigating the use of psychosocial interventions and psychotropic co-medication among stimulant-treated children with attention-deficit hyperactivity disorder (ADHD) in relation to the presence of psychiatric co-morbidity ...
Hugtenburg, J.G., Ruud B. Minderaa, de Jong-van den Berg, Lolkje T. W., Faber, Adrianne, de Jong-van den Berg, L.T.W., Luuk J. Kalverdijk, Minderaa, R.B., Hugtenburg, Jacqueline G., Faber, A., Minderaa, Ruud B., Jacqueline G. Hugtenburg, Adrianne Faber, Lolkje T. W. de Jong-van den Berg, Jong-van den Berg, L.T.W., de, Tobi, H., Jong-van den Berg, Lolkje T. W., Tobi, Hilde, Kalverdijk, Luuk J., Kalverdijk, L.J., Hilde Tobi   +19 more
core   +3 more sources

A systematic review of the safety of lisdexamfetamine dimesylate [PDF]

, 2014
BackgroundHere we review the safety and tolerability profile of lisdexamfetamine dimesylate (LDX), the first long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD).MethodsA PubMed search was conducted for ...
Sorooshian, Shaw, David R. Coghill, Beatriz Caballero, Shaw Sorooshian, Richard Civil, Coghill, David R., Sorooshian, S, Caballero, Beatriz, Civil, R, Coghill, DR, Civil, Richard, Caballero, B   +11 more
core   +1 more source

Signals of increasing co-use of stimulants and opioids from online drug forum data

Harm Reduction Journal, 2022
Background Despite recent rises in fatal overdoses involving multiple substances, there is a paucity of knowledge about stimulant co-use patterns among people who use opioids (PWUO) or people being treated with medications for opioid use disorder (PTMOUD)
Abeed Sarker, Mohammed Ali Al-Garadi, Yao Ge, Nisha Nataraj, Christopher M. Jones, Steven A. Sumner   +5 more
doaj   +1 more source

Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial

Frontiers in Psychiatry, 2022
The increasing prevalence of illicit stimulant use among those in opioid treatment programs poses a significant risk to public health, stimulant users have the lowest rate of retention and poorest outcomes among those in addiction treatment, and current ...
Christopher S. Stauffer, Christopher S. Stauffer, Christopher S. Stauffer, Salem Samson, Alex Hickok, Alex Hickok, William F. Hoffman, William F. Hoffman, Steven L. Batki   +8 more
doaj   +1 more source

Type of medication therapy for ADHD and stimulant misuse during adolescence: a cross-sectional multi-cohort national studyResearch in context

EClinicalMedicine, 2023
Summary: Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with higher substance use rates. Stimulant and non-stimulant pharmacotherapy improve adolescent ADHD, but their associations with prescription stimulant misuse (PSM ...
Ty S. Schepis, Kennedy S. Werner, Olivia Figueroa, Vita V. McCabe, John E. Schulenberg, Phil T. Veliz, Timothy E. Wilens, Sean Esteban McCabe   +7 more
doaj   +1 more source

Cocaine or methamphetamine use during young adulthood following stimulant use for attention-deficit/hyperactivity disorder during adolescence.

, 2023
Importance: The prescribing of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) has increased in the US. Prescription stimulants are one of the most commonly misused controlled substances during adolescence.
Schepis, Ty S, Wilens, Timothy E, Veliz, Phil T, McCabe, Vita V, Schulenberg, John E, McCabe, Sean Esteban   +5 more
core   +1 more source

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Background: Concurrent therapeutic prescribing of prescription stimulants with opioid analgesics is increasing in the United States. Stimulant medication use is associated with increased risk for long-term opioid therapy (LTOT), and LTOT is associated ...
Jeffrey F. Scherrer, Joanne Salas, Richard Grucza, Timothy Wilens, Patrick D. Quinn, Mark D. Sullivan, Rebecca C. Rossom, Eric Wright, Brian Piper, Katherine Sanchez, Gwen Lapham   +10 more
doaj   +1 more source

Current issues around the pharmacotherapy of ADHD in children and adults [PDF]

, 2009
Background New drugs and new formulations enter the growing market for ADHD medication. The growing awareness of possible persistence of ADHD impairment beyond childhood and adolescence resulting in increased pharmacotherapy of ADHD in adults, is also a ...
Tobi, H., Els den Ban, van den Ban, E., Ban, E., van den, Faber, A., Hilde Tobi, Meijer, W.M., Adrianne Faber, Willemijn M. Meijer   +8 more
core   +1 more source

Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders

Brain Sciences, 2023
Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction, including interventions that focus on prescribing pharmaceutical-grade psychoactive substances, such as opioids, instead of illicit versions, intending to mitigate fatal
Anees Bahji, Marlon Danilewitz, David Crockford   +2 more
doaj   +1 more source